Corporate Overview - PRA Health Sciences

C O R P O R AT E O V E R V I E W
THE FUTURE
OF CLINICAL
DEVELOPMENT
PRA Health Sciences (PRA) provides innovative drug development solutions across
all phases and therapeutic areas. But innovation just for the sake of innovation isn’t
why we do it. Side-by-side with our clients, we strive to move drug discovery forward,
to help them develop life-saving and life-improving drugs. We help change people’s
lives for the better every day. It’s who we are. Innovating to help people is at the
heart of our process, but it’s even more than that. It’s also our privilege.
EXPERIENCE
EXPERTISE
N o . O F COU NTRI E S WI TH
CO V E R A GE
80+
10,000+
3,300+
When a sponsor chooses you to help develop one of its promising compounds, it’s a compliment
laden with great responsibility. At PRA, we understand and embrace that responsibility, having
worked on 100+ marketed drugs across several therapeutic areas and conducted the pivotal or
supportive trials that led to FDA and/or international regulatory approval of 50+ such drugs.
Neurology &
Psychiatry
Gastroenterology
3
Infectious
Diseases
Genitourinary
3
4
Immunology
5
7
12
16
N o . O F E MP LOY E E S
CardioMetabolic
Oncology &
Hematology
Respiratory
3
Diagnostics
2
N o . O F CL I NI CA L STU D I ES *
COMPREHENSIVE PHASE I-IV DRUG
DEVELOPMENT
* O VER TH E PA S T 5 YEA R S
TECHNOLOGY
EMPOWERS US TO
CONNECT INSIGHTS
AND MOVE IN
ANY DIRECTION.
ESPECIALLY
FORWARD.
2 Bioanalytical
Laboratories
Strategic Solutions
US and EU
Staff Augmentation
FSP
Embedded Solutions
8 Clinical
Pharmacology Units
Post-Marketing
Research
Clinical
Development
6 Global Drug
Safety Centers
3 in the US
5 in the EU
Phase II-III Studies
“It isn’t enough to just be
in multiple regions. Your
project teams need to know
how to harness this knowledge
and to use it to make quality
decisions that are aligned
with the study goals.”
SEAN LEECH,
Executive Vice President,
Product Registration
(Europe, Asia Pacific, and Africa)
PRA OFFICES
PRA COVERAGE
Tailored Approach
to Real-world Research
PRA’s operational
model encourages
employees to
initiate creative
solutions to keep
projects on track
when they
encounter the
need. It’s this
culture of flexibility
and support that
enables us to
search for the
right answer to
any given problem,
and to be able to
utilize those
answers in providing
better solutions for
our clients.
The story of PRA Health Sciences would naturally talk about
how we’ve become one of the world’s largest CROs. It would
talk about our innovation and growth and would speak to our
operational efficiencies and transparency. It would highlight
our expertise and customization. And it would touch on the
incredible differences we’ve made, over our more than 30
years, in helping to bring to market everything from niche
treatments and therapies to blockbuster drugs.
More than anything else, our story would be about people.
Not only our over 10,000 employees operating in more than
80 countries, though they’d certainly be a big part of it, but
also the people that inspire them. The heroes of any PRA
Health Sciences story are the clients we serve and the people
whose lives we help improve, all over the world. And our story
has only just begun.
PRA
PRA Health
Health Sciences
Sciences conducts
conducts comprehensive
comprehensive Phase
phase I-IV
I-IV biopharmaceutical
biopharmaceutical drug
drug development.
development.
To
To learn
learn more
more about
about our
our solutions,
solutions, please
please visit
visit us
us at
at prahs.com
prahs.com or
or email
email us
us at
at [email protected]
[email protected]